BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22669410)

  • 1. Microsatellite instability testing in Korean patients with colorectal cancer.
    Oh JR; Kim DW; Lee HS; Lee HE; Lee SM; Jang JH; Kang SB; Ku JL; Jeong SY; Park JG
    Fam Cancer; 2012 Sep; 11(3):459-66. PubMed ID: 22669410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified MSI marker panel for diagnosis of colorectal cancer.
    Shemirani AI; Haghighi MM; Zadeh SM; Fatemi SR; Taleghani MY; Zali N; Akbari Z; Kashfi SM; Zali MR
    Asian Pac J Cancer Prev; 2011; 12(8):2101-4. PubMed ID: 22292659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability.
    Gologan A; Krasinskas A; Hunt J; Thull DL; Farkas L; Sepulveda AR
    Arch Pathol Lab Med; 2005 Nov; 129(11):1390-7. PubMed ID: 16253017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors.
    Agostini M; Enzo MV; Morandi L; Bedin C; Pizzini S; Mason S; Bertorelle R; Urso E; Mescoli C; Lise M; Pucciarelli S; Nitti D
    Cancer Biomark; 2010; 6(1):49-61. PubMed ID: 20164541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a fluorescent multiplex assay for detection of MSI-High tumors.
    Bacher JW; Flanagan LA; Smalley RL; Nassif NA; Burgart LJ; Halberg RB; Megid WM; Thibodeau SN
    Dis Markers; 2004; 20(4-5):237-50. PubMed ID: 15528789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations.
    Pedroni M; Roncari B; Maffei S; Losi L; Scarselli A; Di Gregorio C; Marino M; Roncucci L; Benatti P; Ponti G; Rossi G; Menigatti M; Viel A; Genuardi M; de Leon MP
    Dis Markers; 2007; 23(3):179-87. PubMed ID: 17473388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of each Bethesda marker in defining microsatellite instability when screening for Lynch syndrome.
    Sinn DH; Chang DK; Kim YH; Rhee PL; Kim JJ; Kim DS; Park CK; Kim JW; Yun SH; Lee WY; Chun HK; Rhee JC
    Hepatogastroenterology; 2009; 56(91-92):672-6. PubMed ID: 19621678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent MSI mononucleotide markers for diagnosis of hereditary nonpolyposis colorectal cancer.
    Haghighi MM; Javadi GR; Parivar K; Milanizadeh S; Zali N; Fatemi SR; Zali MR
    Asian Pac J Cancer Prev; 2010; 11(4):1033-5. PubMed ID: 21133620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loci for efficient detection of microsatellite instability in hereditary non-polyposis colorectal cancer.
    Frazier ML; Sinicrope FA; Amos CI; Cleary KR; Lynch PM; Levin B; Luthra R
    Oncol Rep; 1999; 6(3):497-505. PubMed ID: 10203581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression.
    Dietmaier W; Wallinger S; Bocker T; Kullmann F; Fishel R; Rüschoff J
    Cancer Res; 1997 Nov; 57(21):4749-56. PubMed ID: 9354436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and accurate approach for screening of microsatellite unstable tumours using quasimonomorphic mononucleotide repeats and denaturating high performance liquid chromatography (DHPLC).
    Berginc G; Glavac D
    Dis Markers; 2009; 26(1):19-26. PubMed ID: 19242065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denaturing high performance liquid chromatography for the detection of microsatellite instability using bethesda and pentaplex marker panels.
    Soong R; Anuar D; Liu Y; Eu KW; Han HC; Salto-Tellez M; Iacopetta B
    Diagn Mol Pathol; 2008 Sep; 17(3):127-33. PubMed ID: 18382367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of MT1XT20 Single Quasi-Monomorphic Mononucleotide Marker for Characterizing Microsatellite Instability in Persian Lynch Syndrome Patients.
    Farahani N; Nikpou P; Emami MH; Hashemzadeh M; Zeinalian M; Shariatpanahi SS; Salehi R
    Asian Pac J Cancer Prev; 2016; 17(9):4259-4265. PubMed ID: 27797228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 [correction of hMLH6] immunostaining.
    Rigau V; Sebbagh N; Olschwang S; Paraf F; Mourra N; Parc Y; Flejou JF
    Arch Pathol Lab Med; 2003 Jun; 127(6):694-700. PubMed ID: 12741892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity and polymorphism of Bethesda panel markers in Chinese population.
    Zheng Y; Chen J; Zhang X; Xie L; Zhang Y; Sun Y
    Bull Cancer; 2020 Nov; 107(11):1091-1097. PubMed ID: 32980144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved testing for microsatellite instability in colorectal cancer using a simplified 3-marker assay.
    Esemuede I; Forslund A; Khan SA; Qin LX; Gimbel MI; Nash GM; Zeng Z; Rosenberg S; Shia J; Barany F; Paty PB
    Ann Surg Oncol; 2010 Dec; 17(12):3370-8. PubMed ID: 20703819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.
    Pucciarelli S; Agostini M; Viel A; Bertorelle R; Russo V; Toppan P; Lise M
    Dis Colon Rectum; 2003 Mar; 46(3):305-12. PubMed ID: 12626904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer.
    Jin HY; Liu X; Li VK; Ding Y; Yang B; Geng J; Lai R; Ding S; Ni M; Zhao R
    BMC Cancer; 2008 Feb; 8():44. PubMed ID: 18257912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Three Customized MSI Panels to Improve the Detection of Microsatellite Instability in Gastric Cancer.
    Park J; Shin S; Yoo HM; Lee SW; Kim JG
    Clin Lab; 2017 Apr; 63(4):705-716. PubMed ID: 28397474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAT25 is a mononucleotide marker to identify HNPCC patients.
    Bianchi F; Galizia E; Catalani R; Belvederesi L; Ferretti C; Corradini F; Cellerino R
    J Mol Diagn; 2009 May; 11(3):248-52. PubMed ID: 19324995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.